Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | August 16, 2006 | ||||
Last Updated Date | December 21, 2007 | ||||
Start Date † | April 2005 | ||||
Current Primary Outcome Measures † |
Caregiver affect and adjustment [ Time Frame: 1 year post patient death ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | Complete list of historical versions of study NCT00365963 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
Clinician-Patient-Caregiver Communication [ Time Frame: throughout study ] [ Designated as safety issue: No ] | ||||
Original Secondary Outcome Measures † | Same as current | ||||
Descriptive Information | |||||
Brief Title † | Web-Based Intervention for Lung Cancer Patients and Their Informal Caregivers | ||||
Official Title † | Clinician Integration Study | ||||
Brief Summary | The purpose of this study is to find out if patients with lung cancer and their main informal caregiver (person providing physical, emotional, or financial support) are helped by getting information, support, and decision making tools through a computer system called CHESS(the Comprehensive Health Enhancement Support System) |
||||
Detailed Description | Many patients and their family/friends use the internet for obtaining information regarding the cancer diagnosis and treatment. In this study, the main caregiver of patients with advance (stage III or IV) non-small cell lung cancer is provided with a computer and internet access. Approximately one-half of the participants will also receive CHESS. |
||||
Study Phase | Phase III | ||||
Study Type † | Interventional | ||||
Study Design † | Other, Randomized, Open Label, Uncontrolled, Factorial Assignment, Efficacy Study | ||||
Condition † | Non-Small Cell Lung Cancer | ||||
Intervention † | Device: Comprehensive Health Enhancement Support System | ||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Active, not recruiting | ||||
Enrollment † | 252 | ||||
Estimated Completion Date | May 2009 | ||||
Estimated Primary Completion Date | December 2010 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 18 Years and older | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† | |||||
Location Countries † | United States | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00365963 | ||||
Responsible Party | David Gustafason, School of engineering | ||||
Secondary IDs †† | NCI#5 P50 CA095817-03 | ||||
Study Sponsor † | University of Wisconsin, Madison | ||||
Collaborators †† | National Cancer Institute (NCI) | ||||
Investigators † |
|
||||
Information Provided By | University of Wisconsin, Madison | ||||
Verification Date | December 2007 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |